Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Zangari

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Clinical Advances in Hematology & Oncology : H&O|November 14, 2006
Anticoagulation regimens for thalidomide and lenalidomideMaurizio Zangari
Bone|March 8, 2016
The effects of proteasome inhibitors on bone remodeling in multiple myelomaMaurizio Zangari, Larry J Suva
Current Opinion in Supportive and Palliative Care|July 27, 2010
Bone and paraproteinemiasMaurizio Zangari, Fenghuang Zhan, Guido Tricot
European Journal of Haematology|May 25, 2012
Low-risk identification in multiple myeloma using a new 14-gene modelTiehua Chen, Tamara Berno, Maurizio Zangari
Current Pharmaceutical Biotechnology|December 16, 2006
Farnesyltransferase inhibitors and rapamycin in the treatment of multiple myelomaMaurizio Zangari, Federica Cavallo, Guido Tricot
Biomed Research International|May 23, 2015
Drug resistance in hematologic malignancies: induction mechanisms, genetics, and therapeuticsFenghuang Zhan, Maurizio Zangari, Lugui Qiu
Expert Opinion on Investigational Drugs|November 1, 2005
Immunomodulatory drugs in multiple myelomaMaurizio Zangari, Francesca Elice, Guido Tricot
Cancer Treatment and Research|April 21, 2009
Bleeding disorders associated with cancer dysproteinemiasMaurizio Zangari, F Elice, G Tricot, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimensMaurizio Zangari, Louis Fink, Fenghuang Zhan, et al.
Seminars in Oncology|January 10, 2003
High-dose therapy and immunomodulatory drugs in multiple myelomaBart Barlogie, John Shaughnessy, Maurizio Zangari, et al.
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Clinical Advances in Hematology & Oncology : H&O|November 14, 2006
Anticoagulation regimens for thalidomide and lenalidomideMaurizio Zangari
Bone|March 8, 2016
The effects of proteasome inhibitors on bone remodeling in multiple myelomaMaurizio Zangari, Larry J Suva
Current Opinion in Supportive and Palliative Care|July 27, 2010
Bone and paraproteinemiasMaurizio Zangari, Fenghuang Zhan, Guido Tricot
European Journal of Haematology|May 25, 2012
Low-risk identification in multiple myeloma using a new 14-gene modelTiehua Chen, Tamara Berno, Maurizio Zangari
Current Pharmaceutical Biotechnology|December 16, 2006
Farnesyltransferase inhibitors and rapamycin in the treatment of multiple myelomaMaurizio Zangari, Federica Cavallo, Guido Tricot
Biomed Research International|May 23, 2015
Drug resistance in hematologic malignancies: induction mechanisms, genetics, and therapeuticsFenghuang Zhan, Maurizio Zangari, Lugui Qiu
Expert Opinion on Investigational Drugs|November 1, 2005
Immunomodulatory drugs in multiple myelomaMaurizio Zangari, Francesca Elice, Guido Tricot
Cancer Treatment and Research|April 21, 2009
Bleeding disorders associated with cancer dysproteinemiasMaurizio Zangari, F Elice, G Tricot, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimensMaurizio Zangari, Louis Fink, Fenghuang Zhan, et al.
Seminars in Oncology|January 10, 2003
High-dose therapy and immunomodulatory drugs in multiple myelomaBart Barlogie, John Shaughnessy, Maurizio Zangari, et al.
Pageof 20